James Xue, Founder and CEO of CANbridge Recognized by “Chaoyang Phoenix High-caliber Overseas Talents 2013”


(Jan 14, 2014, Beijing) – James Xue, Founder and CEO of CANbridge Life Sciences received recognition from“Chaoyang Phoenix High-caliber Overseas Talents 2013”today. The Chaoyang Phoenix Project was established in 2010 by Beijing Chaoyang District Municipal Government to recognize and provide financial support to top overseas ethic Chinese entrepreneurs,academic and industry experts providing leadership roles in growing the new economy in the district.  Mr. Xue is a winner of the Entrepreneurship Category.

For more, please contact info@canbridgepharma.com.

About CANbridge
CANbridge Life Sciences, Ltd. is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan).  CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia. 
Led and backed by a highly-seasoned executive team, with extensive Chinese drug development experience, CANbridge has the capability to select, acquire, develop and commercialize future therapeutics and diagnostics targeting the unmet medical needs of Chinese and East Asian patients with serious or critical conditions.
CANbridge is privately-held and headquartered in Beijing, China.  For more on CANbridge Life Sciences Ltd., please go to www.canbridgepharma.com.